The abstract is read at the publisher; the summary is JClub's.
Between 2020 and 2025, trends in dexmedetomidine administration and ICU admissions were examined among hospitalized patients with opioid use disorder in Philadelphia, Pennsylvania.
- Why it matters: It addresses uncertainty about how sedative use relates to critical care utilization in this hospitalized population over time.
- What they did: This cohort study analyzed changes in dexmedetomidine administration and intensive care unit admissions from 2020 through 2025 in Philadelphia, Pennsylvania.
- The result: The study characterizes temporal patterns that can inform how ICU admission rates align with dexmedetomidine use in hospitalized patients with opioid use disorder in Philadelphia.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.